home / stock / smfrw / smfrw news


SMFRW News and Press, Sema4 Holdings Corp. Warrant From 11/03/21

Stock Information

Company Name: Sema4 Holdings Corp. Warrant
Stock Symbol: SMFRW
Market: NASDAQ

Menu

SMFRW SMFRW Quote SMFRW Short SMFRW News SMFRW Articles SMFRW Message Board
Get SMFRW Alerts

News, Short Squeeze, Breakout and More Instantly...

SMFRW - Sema4 to Participate at Three Upcoming Investor Conferences in November

STAMFORD, Conn., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following virtual investor conferences: Stifel 2021 Virtual Healthcare Confe...

SMFRW - Sema4 to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

STAMFORD, Conn., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced it will release financial results for the third quarter of 2021 after the market close on Monday, November 15, 2021. On the same...

SMFRW - Sema4 Appoints Computational Biology Expert Gustavo Stolovitzky as Chief Science Officer

STAMFORD, Conn., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Sema4 , an AI-driven genomic and clinical data intelligence platform company, today announced the appointment of Gustavo Stolovitzky , PhD, to the newly established senior leadership position of Chief Science Officer (CSO). Dr....

SMFRW - Sema4 Launches Sema4 Elements(TM), a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health

STAMFORD, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Sema4 , an AI-driven genomic and clinical data intelligence platform company, today announced the launch of Sema4 Elements™ , a portfolio of information-driven genomic solutions, digital tools for patients and providers, and...

SMFRW - Sema4 to Participate at Two Upcoming Investor Conferences in September

STAMFORD, Conn., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that Eric Schadt , Ph.D., Founder and Chief Executive Officer, and Isaac Ro , Chief Financial Officer will participate at th...

SMFRW - Sema4 Reports Second Quarter 2021 Financial Results and Business Highlights

85% test-volume growth (excluding COVID-19 tests) compared to same period in 2020 Recorded 56% growth in total revenue of $46.9 million Expanded health system partnerships to include NorthShore University, AdventHealth, and Avera Health Commitment to 2023 target ...

SMFRW - Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care

SIOUX FALLS, S.D and STAMFORD, Conn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Avera Health , an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4 , a patient-centered health intelligence company, today announced a new collaboration launch...

SMFRW - Sema4 to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

STAMFORD, Conn., Aug. 02, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced it will release financial results for the second quarter of 2021 after the market cl...

SMFRW - Sema4 to Participate at Two Upcoming Investor Conferences in August

STAMFORD, Conn., July 28, 2021 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate at two upcoming virtual i...

Previous 10 Next 10